Abstract:Ischemic cerebrovascular diseases relate to a variety of large vessel and small vessel angiopathies, which are common causes of ischemic stroke and cognitive dysfunction especially in the elderly population [1; 2; 3; 4; 5]. Although complex pathologic processes and high rates of morbidity make ischemic cerebrovascular diseases challenging to treat, new clinical evidence continues to emerge for improved understanding of such diseases. Currently, basic and clinical research focusses on modified treatment approaches to accelerate the understanding of the disease, to improve patient care and monitoring, and, ultimately, to reduce patient morbidity and mortality, with application of advanced neuroimaging techniques being used for biomarker development and testing in this regard [6; 7; 8; 9; 10]. Furthermore, recent major topics focused on aspects of advanced brain function, given that chronic ischemic conditions are also increasingly recognized as relevant risk factors for clinically silent brain infarctions and cognitive impairment [11; 12; 13; 14]. Two studies of the Research Topic investigated patients with Moyamoya disease (MMD) [15; 16]. Specifically, MMD is a cerebrovascular disorder with typically progressive steno-occlusive disease predominantly involving the bilateral intracranial internal carotid artery (ICA) together with the proximal branches [17; 18]. The disease is mainly observed in Japan, whereas the incidence in other parts of the world is rather low [17; 19; 20]. The disease can entail symptoms related to brain ischemia (e.g., stroke) and/or related to compensatory mechanisms that can occur in response to ischemia (e.g., hemorrhage from fragile collateral vessels) [17; 18]. In the report by Cao et al., hemodynamic abnormalities in 42 patients with MMD were examined before and after intervention by combined revascularization (i.e., surgery involving a direct superficial temporal artery-middle cerebral artery bypass and an indirect encephalo-arterio-synangiosis bypass) using intraoperative FLOW800, a specialized software utilizing indocyanine green video-angiography to analyze data and generate color delay mapping [16]. The courses of parameters and associations between intraoperative FLOW800 and color Doppler ultrasonography (CDUS) measurements were evaluated, showing that both the intraoperatively measured delay time (i.e., the time interval between 0 and 50% of maximum fluorescence intensity for FLOW800 analysis) and rise time (i.e., the time interval between 10 and 90% of the maximum fluorescence intensity for FLOW800 analysis) substantially decreased in the recipient artery and vein [16]. Microvascular transit time from intraoperative assessment was significantly reduced after surgery, and all postoperatively collected parameters from CDUS exhibited significant changes in comparison to the preoperative state [16]. Significant associations between microvascular transit time, resistance index, and pulsatility index were observed [16]. Based on the finding that hemodynamic outcomes of the donor and recipient arteries demonstrated significant changes following bypass surgery, the authors concluded that the parameter of time may be more precise and sensitive for assessment of hemodynamics using FLOW800, while multiple evaluations of hemodynamics could offer beneficial data for perioperative management in MMD [16]. In the study by Yu et al., metabolites associated with MMD were investigated by means of liquid chromatography coupled with mass spectrometry (LC-MS) to discern metabolic biomarkers in cerebrospinal fluid (CSF) samples [15]. The patient group consisted of 16 patients with MMD, which were compared to a healthy control group of 8 subjects [15]. The CSF samples were obtained during bypass surgery in the patient group and from lumbar puncture (during lumbar anesthesia) in the control group [15]. Overall, 129 significant differential metabolites in the CSF samples were identified when comparing the MMD patients to the healthy controls, which were associated with multiple pathways (e.g., purine metabolism and pyrimidine metabolism, amongst other pathways) [15]. Hence, utilizing an LC-MS-based metabolomics approach may hold promise for enhancing the clinical diagnosis of MMD, and the identified parameters may lead to developments of novel diagnostic markers for MMD regarding the pathogenesis of the disease [15]. Three articles published as part of the Research Topic focused on stroke regarding diagnostics or treatment [21; 22; 23]. Acute stroke is defined by an acute onset of focal neurological deficits stemming from affection of one or more vascular territories of the brain, which can manifest due to loss of blood supply due to ischemic or hemorrhagic stroke [24; 25; 26]. Besides neurological assessment, the diagnostic approach commonly includes imaging of the brain parenchyma, brain-feeding arteries, and oftentimes perfusion imaging using com -Abstract Truncated-

Comparative assessment of macro-,micro- and molecular rheological factors in patients with ischemic stroke. (Preliminary results)

Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.

Investigation of Hemorheological Parameters in Ischemic Stroke Patients

The Study of Erythrocytes Membrane, ATPase Activities, Hemorheological Changes and Their Correlation in Stroke Patients

Correction of T 1 Effects in Calculation of Relative Recirculation in Ischemic Stroke Patients

The Analysis of Hemorheology in the Atheroscleotic and Ischemic Stroke of the 52 Young Adults

High relative cerebral blood volume is associated with good long term clinical outcomes in acute ischemic stroke: a retrospective cohort study

Evaluation of hemodynamics in stroke patients caused by thrombosis of rheumatic heart disease

Abstract WP128: Susceptibility Weighted Magnetic Resonance Imaging and Regional Cerebrovascular Reservoir Capacity in Angiographically Proven Large Artery Disease in Acute Ischemic Stroke and Transient Ischemic Attack

Individual Patient Data Meta-Analysis of Dynamic Cerebral Autoregulation and Functional Outcome After Ischemic Stroke

A Comparative Study of Hemorheological Parameters in Transient Ischemic Attack and Cerebral Infarction Patients

Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing

Editorial: Advances in chronic ischemic cerebrovascular disease: diagnosis and management

Preliminary Study of Dynamic Cerebral Autoregulation in Acute Ischemic Stroke: Association with Clinical Factors.

Abstract TP159: Baseline Viscoelastic Hemostatic Assays and Associations With DWI Ischemic Lesions in Intracerebral Hemorrhage Patients

Method parameters’ impact on mortality and variability in rat stroke experiments: a meta-analysis

A Multi-Parametric Approach for Characterising Cerebral Haemodynamics in Acute Ischaemic and Haemorrhagic Stroke

INFOMATAS multi-center systematic review and meta-analysis individual patient data of dynamic cerebral autoregulation in ischemic stroke

Serum C-reactive Protein, Fibrinogen and D-dimer in Patients with Progressive Cerebral Infarction

Molecular Profiling of the Stroke-Induced Alterations in the Cerebral Microvasculature Reveals Promising Therapeutic Candidates.

Persistently Elevated Microvascular Resistance Postrecanalization